Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Frontiers Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect

The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic? - ScienceDirect

Frontiers Plant Products as Inhibitors of Coronavirus 3CL Protease

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment - ScienceDirect

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Life, Free Full-Text

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis

Frontiers Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective

IJMS, Free Full-Text